BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27785422)

  • 1. Genetics and biological markers in urachal cancer.
    Behrendt MA; van Rhijn BW
    Transl Androl Urol; 2016 Oct; 5(5):655-661. PubMed ID: 27785422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.
    Behrendt MA; DE Jong J; VAN Rhijn BW
    Minerva Urol Nefrol; 2016 Apr; 68(2):172-84. PubMed ID: 26583595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer.
    Stokkel LE; van Rossum HH; van de Kamp MW; Boellaard TN; Bekers EM; Kok NFM; van Rhijn BWG; Mertens LS
    Urol Oncol; 2023 Jul; 41(7):326.e17-326.e24. PubMed ID: 36813613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
    Song SH; Lee J; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
    Cancer Res Treat; 2023 Oct; 55(4):1337-1345. PubMed ID: 37080605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.
    Mertens LS; Behrendt MA; Mehta AM; Stokkel L; de Jong J; Boot H; Horenblas S; van der Heijden MS; Moonen LM; Aalbers AGJ; Meinhardt W; van Rhijn BWG
    Eur J Surg Oncol; 2019 Sep; 45(9):1740-1744. PubMed ID: 31003721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation.
    Wang T; Lv Z; Feng H; Li J; Cui B; Yang Y; Huang X; Zhang X; Li X; Ma X
    Front Oncol; 2022; 12():860133. PubMed ID: 35646691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
    Flammia RS; Chierigo F; Würnschimmel C; Horlemann B; Hoeh B; Sorce G; Tian Z; Leonardo C; Tilki D; Terrone C; Saad F; Shariat SF; Montorsi F; Chun FK; Gallucci M; Karakiewicz PI
    Urol Oncol; 2022 Apr; 40(4):165.e9-165.e15. PubMed ID: 34686429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra.
    Stokkel LE; van Montfoort ML; van Boven HH; Mertens LS; van Rhijn BWG
    Eur Urol Open Sci; 2021 Nov; 33():56-60. PubMed ID: 34622223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
    Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
    Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical and chemotherapeutic experience regarding a urachal carcinoma with repeated relapse: case report and literature review.
    Zong L; Chen P
    World J Surg Oncol; 2013 Aug; 11():170. PubMed ID: 23914849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
    Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
    Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
    JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
    Reis H; Krafft U; Niedworok C; Módos O; Herold T; Behrendt M; Al-Ahmadie H; Hadaschik B; Nyirady P; Szarvas T
    Dis Markers; 2018; 2018():7308168. PubMed ID: 29721106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
    Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
    Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
    Pires-Luis AS; Martinek P; Alaghehbandan R; Trpkov K; Comperat EM; Perez Montiel DM; Bulimbasic S; Lobo J; Henrique R; Vanecek T; Pivovarcikova K; Michalova K; Pitra T; Hora M; Marques A; Lopes JM; Rogala J; Mareckova J; Michal M; Hes O
    Adv Anat Pathol; 2020 Sep; 27(5):303-310. PubMed ID: 32520749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Laparoscopy and Abdominal Cytology Reliably Detect Peritoneal Metastases in Patients with Urachal Adenocarcinoma.
    Stokkel LE; Mehta AM; Behrendt MA; de Jong J; Bekers EM; Hendricksen K; Aalbers AGJ; Kok NFM; Meinhardt W; Mertens LS; van Rhijn BWG
    Ann Surg Oncol; 2020 Jul; 27(7):2468-2475. PubMed ID: 32052302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Riva G; Mian C; Luchini C; Girolami I; Ghimenton C; Cima L; Novelli L; Hanspeter E; Mazzoleni G; Schwienbacher C; Pycha S; D'Elia C; Trenti E; Pycha A; Martignoni G; Hes O; Eccher A; Nesi G; Brunelli M
    Virchows Arch; 2019 Jan; 474(1):13-20. PubMed ID: 30302546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urachal Cancer: an update of current molecular findings].
    Reis H; Mairinger F; Ting S; Nagy N; Witzke KE; Kohl M; Sitek B; Niedworok C; Hadaschik B; Nyirády P; Szarvas T
    Pathologe; 2019 Dec; 40(Suppl 3):239-243. PubMed ID: 31705235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term clinical results of 5 cases of urachal carcinoma].
    Kajita Y; Habuchi T; Kamoto T; Okuno H; Terai A; Kakehi Y; Terachi T; Ogawa O; Yoshida O
    Hinyokika Kiyo; 2000 Oct; 46(10):711-4. PubMed ID: 11215196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urachal carcinoma: surgical and chemotherapeutic options.
    Siefker-Radtke A
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1715-21. PubMed ID: 17181485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.